Results 51 to 60 of about 614 (160)

Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey

Therapeutic Advances in Rare Disease, 2023
In response to the social inequities that exist in health care, the NIH-funded Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) recently formed a diversity committee to examine systemic racism and implicit bias in the care and ...
Mirna Chehade, Glenn Furuta, Amy Klion, J Pablo Abonia, Seema Aceves, Paroma Bose, Margaret H. Collins, Carla Davis, Evan S. Dellon, Grant Eickel, Gary Falk, Sandeep Gupta, Girish Hiremath, Amari Howard, Elizabeth T. Jensen, Susamita Kesh, Paneez Khoury, Kendra Kocher, Ellyn Kodroff, Shay Kyle, NaDea Mak, Dawn McCoy, Pooja Mehta, Paul Menard-Katcher, Vincent Mukkada, Ally Paliana, Marc Rothenberg, Kathleen Sable, Cara Schmitt, Melissa Scott, Jonathan Spergel, Mary Jo Strobel, Joshua B. Wechsler, Guang-Yu Yang, Amy Zicarelli, Amanda B. Muir, Benjamin L. Wright, Dominique D. Bailey   +37 more
doaj   +1 more source

Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin‐degrading enzyme, a new molecular vulnerability in multiple myeloma

British Journal of Pharmacology, Volume 183, Issue 12, Page 3355-3376, June 2026.
Inhibitors of insulin‐degrading enzyme boost PI cytotoxicity through an increased sensitivity of proteasome to PI inhibitors, induction of ISR, DNA damage and Myc down‐regulation. They overcome PI resistance in vitro and induce tumour regression in vivo.
Laetitia Lesire, Rebecca Deprez‐Poulain, Damien Bosc, Florence Leroux, Valerie Landry, Sarah Ourabah, Morgane Tardy, Clara Maillard, Ronan Gealageas, Julie Dumont, Adrien Herledan, Sandrine Warenghem, Manon Cruette, Celine Lenglart, Alexandre Biela, Catherine Piveteau, Eva De Smedt, Catharina Muylaert, Wenguang Liang, Elvira Garcia De Paco, Elina Alaterre, Sara Ovejero, Nicolas Robert, Fabien Delahaye, Wei‐Jen Tang, Peter van Endert, Elke De Bruyne, Jérôme Moreaux, Benoit Deprez   +28 more
wiley   +1 more source

Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review

Journal of Allergy and Clinical Immunology: Global
Background: The demographic characteristics of patients with eosinophilic gastrointestinal diseases (EGIDs) are poorly understood. Population-based assessments of EGID demographics may indicate health disparities in diagnosis.
Mirna Chehade, MD, MPH, Benjamin L. Wright, MD, Samantha Walsh, MLS, MA, Dominique D. Bailey, MD, Amanda B. Muir, MD, Amy D. Klion, MD, Margaret H. Collins, MD, Carla M. Davis, MD, Glenn T. Furuta, MD, Sandeep Gupta, MD, Paneez Khoury, MD, Kathryn A. Peterson, MD, Elizabeth T. Jensen, PhD   +12 more
doaj   +1 more source

Language Vitality Reassessment and Revival Efforts for Bidayuh of Sarawak, Malaysia

Journal of the Southeast Asian Linguistics Society
The Bidayuh language has been characterized as having stable vitality in some studies and shifting status in others. An Ethnologue update labels two Bidayuh dialects as endangered, but little is known about language use in the Bidayuh community and the ...
Ting, Su-Hi, Kayad, Florence Gilliam
doaj   +1 more source

A Rare Case of Eosinophilic Gastroenteritis and Ampullitis Leading to Benign Papillary Stenosis

Case Reports in Gastrointestinal Medicine, 2021
Eosinophilic gastroenteritis is characterized by eosinophilic infiltration of the gastrointestinal wall. There have been limited studies of eosinophilic infiltration involving the ampulla.
Akwe Nyabera, Keya Shah, Nso Nso, Saphwat Eskaros, Negar Niknam   +4 more
doaj   +1 more source

An evaluation of So language vitality in Thailand [PDF]

Journal of the Southeast Asian Linguistics Society, 2017
This paper explores the vitality and endangerment of So [sss] speech communities in Thailand. Beginning with a review of sociolinguistic survey results for five So communities in Thailand to ascertain the likely need for vernacular language development ...
Thomas M. Tehan, Linda Markowski
doaj  

A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report

Allergy, Volume 81, Issue 4, Page 1024-1038, April 2026.
ABSTRACT The European Academy of Allergy and Clinical Immunology (EAACI) established a Task Force to assess the existing data on the relationship between eosinophilic esophagitis (EoE) and allergen immunotherapy (AIT). This systematic review and meta‐analysis aimed to study the incidence of confirmed EoE, developing as a side effect of AIT to food or ...
Carlo Maria Rossi, Ingrid Terreehorst, Evaggelia Apostolidou, Martina Votto, Arzu Bakirtas, Antonella Cianferroni, George N. Konstantinou, Katerina Pantavou, Dario Antolin‐Amerigo, Enrico Heffler, Alberto Alvarez‐Perea, Montserrat Fernandez‐Rivas, Georgios K. Nikolopoulos, Oliver Pfaar, Constantinos Pitsios   +14 more
wiley   +1 more source

Esophageal Involvement in Non–Eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases: Association With Esophageal Symptoms and Gastric Involvement

JGH Open, Volume 10, Issue 7, July 2026.
Yasuhiko Abe, Naoko Mizumoto, Yu Sasaki, Makoto Yagi, Yusuke Onozato, Yoshiyuki Ueno   +5 more
wiley   +1 more source

Eosinophilic peritonitis with colon cancer: a case report

BMC Gastroenterology, 2020
Background Eosinophilic gastrointestinal disorders (EGIDs) are a rare group of inflammatory disorders that can occur anywhere along the gastrointestinal tract, from the esophagus to the rectum.
Ryo Ataka, Hirokazu Tanaka, Shintaro Yagi, Kei Yamane, Kenji Yoshino, Tomoyuki Miyauchi, Tomoaki Yoh, Keiichi Arafuka, Shinichi Fujita, Akihiko Hamada, Bunji Endo, Shinji Uemoto   +11 more
doaj   +1 more source

Eosinophilic Gastrointestinal Disease After Pediatric Organ and Bone Marrow Transplantation

JGH Open, Volume 10, Issue 1, January 2026.
ABSTRACT Background Previous studies have shown an increased prevalence of eosinophilic gastrointestinal disease (EGID) in pediatric liver and heart transplant recipients. However, EGID after other solid organ and bone marrow transplantations has not been extensively evaluated.
Erin Sinai, Bridget E. Wilson, Melissa Pecak, Shauna Schroeder, Edward L. Swing, Cindy Bauer   +5 more
wiley   +1 more source